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Abstract
Background: The use of computerized image analysis for the study of nuclear texture features has provided important
prognostic information for several neoplasias. Recently fractal characteristics of the chromatin structure in routinely stained
smears have shown to be independent prognostic factors in acute leukemia. In the present study we investigated the
influence of the fractal dimension (FD) of chromatin on survival of patients with multiple myeloma.
Methodology: We analyzed 67 newly diagnosed patients from our Institution treated in the Brazilian Multiple Myeloma
Study Group. Diagnostic work-up consisted of peripheral blood counts, bone marrow cytology, bone radiograms, serum
biochemistry and cytogenetics. The International Staging System (ISS) was used. In every patient, at least 40 digital nuclear
images from diagnostic May-Grünwald-Giemsa stained bone marrow smears were acquired and transformed into pseudo-
3D images. FD was determined by the Minkowski-Bouligand method extended to three dimensions. Goodness-of-fit of FD
was estimated by the R2 values in the log-log plots. The influence of diagnostic features on overall survival was analyzed in
Cox regressions. Patients that underwent autologous bone marrow transplantation were censored at the day of
transplantation.
Principal Findings: Median age was 56 years. According to ISS, 14% of the patients were stage I, 39% were stage II and 47%
were stage III. Additional features of a bad prognosis were observed in 46% of the cases. When stratifying for ISS, both FD
and its goodness-of-fit were significant prognostic factors in univariate analyses. Patients with higher FD values or lower
goodness-of-fit showed a worse outcome. In the multivariate Cox-regression, FD, R2, and ISS stage entered the final model,
which showed to be stable in a bootstrap resampling study.
Conclusions: Fractal characteristics of the chromatin texture in routine cytological preparations revealed relevant
prognostic information in patients with multiple myeloma.
Citation: Ferro DP, Falconi MA, Adam RL, Ortega MM, Lima CP, et al. (2011) Fractal Characteristics of May-Grünwald-Giemsa Stained Chromatin Are Independent
Prognostic Factors for Survival in Multiple Myeloma. PLoS ONE 6(6): e20706. doi:10.1371/journal.pone.0020706
Editor: Moray Campbell, Roswell Park Cancer Institute, United States of America
Received December 15, 2010; Accepted May 8, 2011; Published June 16, 2011
Copyright:  2011 Ferro et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This investigation was supported by the São Paulo Research Foundation (project 2007/52015-0) and the National Council of Technological and
Scientific Development (CNPq) project 479074/2008-9. KM, IL-M, CSPL and CAS are researchers of CNPq. DPF recieved a grant as a postgraduate student from
Coordenação de Aperfeiçoamento de Pessoal de Nı́vel Superior. The funding agencies had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript. No writing assistance was utilized in the production of this manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: kmetze@pq.cnpq.br
Introduction
Multiple myeloma (MM) is a clonal proliferation of malignant
plasma cells characterized by a very heterogeneous disease
outcome, varying from relatively asymptomatic slowly progressing
forms to a frankly aggressive course. Moreover, important
variations in tumor cell biology have been described, thus
revealing a heterogeneous disorder [1]. In 2005 the International
Staging System (ISS) was introduced, based on the serum
concentrations of ß2-microglobulin and albumin, which provide
prognostic stratification of the patients [1–5]. However, patient’s
age, degree of anemia, serum creatinine and calcium levels,
dehydrogenase activity (LDH) as well as cytogenetic abnormalities
have been described as additional prognostic factors [1,3,5].
Plasma cell morphology has also been recognized as an
independent prognostic factor for more than two decades [1,6].
However, the recognition of prognostically relevant cell atypias
and maturation of the neoplastic plasma cells is dependent on the
morphologist’s expertise, thus leading to a considerable inter-
observer variability. On the other hand, experimental studies using
computerized image analysis have shown that subvisible modifi-
cations of the chromatin architecture in myeloma cells are
associated with important changes of cell physiology, such as
acquired drug resistance [7]. The quantitative analysis of the
distribution pattern of chromatin and other nuclear components
has been shown to be of prognostic importance in several
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neoplasias [8–15]. Therefore, we would expect that chromatin
texture features in myeloma cells might reveal characteristics
related to the aggressiveness of the tumor.
Scale-invariant self-similarity is an important feature of many
biological structures. It cannot be described adequately by classic
Euclidean geometry, but may be estimated by the determination
of the fractal dimension. There is increasing use of fractal
geometry for medical signal analysis with applications to pattern
recognition, texture analysis and segmentation [16–25]. This
analysis has also been applied for the study of cell nuclei, as the
fractal nature of chromatin and its surrounding nucleoplasmic
space has been demonstrated by different methods [26–28].
Moreover, the fractal characteristics of nuclear chromatin
measured in cytological or histological preparations have shown
to be of prognostic importance in several neoplasias [10,13,14,28–
33].
Therefore we investigated whether the fractal dimension of
nuclear chromatin measured in routinely stained cytological




We analyzed retrospectively consecutive newly diagnosed
patients with multiple myeloma treated at our Institution, where
clinical data, diagnostic bone marrow (BM) smears, and
cytogenetic analyses were available. The study was approved by
the Ethics Committee of the Faculty of Medical Sciences,
University of Campinas (process 365/2002). Patients gave written
informed consent for participation in the study.
MM was diagnosed using the criteria of the International
Myeloma Working Group, based on serum protein electrophore-
sis, presence of proteinuria, bone marrow cytology and bone
radiograms [34]. The data about peripheral blood (PB) counts,
bone marrow cytology, bone radiograms, serum biochemistry
(calcium, albumin, creatinine and beta-2-microglobulin) and
cytogenetics were recorded. Only patients that fulfilled the criteria
for chemotherapy were included. Those with asymptomatic
(smoldering) myeloma, immunoglobulin IgM–related disorders
or with primary amyloidosis were excluded.
Staging was performed according to the ISS [2]. Moreover,
using the criteria of Greipp et al [2], patients were classified as
belonging to the very poor prognosis group, if one or more of the
following criteria were fulfilled: serum ß2-microglobulin .10 mg/
L, serum creatinine .4 mg/dL, serum albumin ,2.5 g/dL, and
platelet count ,1306109/l.
Cytogenetics had been performed in the diagnostic BM
according to the method of Brigadeau et al [35]. In brief, BM
nucleated cells were obtained by Ficoll-Hypaque centrifugation of
the aspirated material. They were cultured for 72 hours in
RPMI1640 supplemented with fetal calf serum. Cultures were
performed both without stimulation, and with stimulation by IL-6
and GM-CSF. G-banding was analyzed, chromosome number
and specific abnormalities were recorded.
Furthermore we looked for the presence of unfavorable
cytogenetic alterations, such as hypodiploidy, deletion of chromo-
some 13, t(4;14), t(14:16), or 17p–, and counted for each patient
the number of cytogenetic abnormalities.
The patients had been treated according to the Brazilian
Multiple Myeloma Study Group [36] which consisted of an
induction chemotherapy with VAD (vincristine 0.4 mg IV day 1,
doxorubicin 9 mg/m2 IV day 1 and oral dexamethasone 40 mg
daily), stem cell mobilization with cyclophosphamide (4 g/m2 IV),
autologous bone marrow transplantation, and then randomized to
test the utility for post-transplantation maintenance treatment
using thalidomide.
Survival was measured from the diagnosis to time of death or
last follow-up. Patients that underwent autologous bone marrow
transplantation were censored at the day of transplantation.
Morphometry
May-Grünwald-Giemsa stained bone marrow slides made at
diagnosis were retrieved from the files. Neoplastic plasma cells
were acquired in 24-bit color bitmap format with a Leica DC 500
(tm) digital camera (resolution of 12 megapixels, oil immersion
objective 6100).
Randomly chosen, non-overlapping tumor nuclei were cap-
tured, interactively segmented and then converted to 8 bit gray
scale with levels of luminance ranging between 0 and 255 (Fig. 1).
Figure 1. Segmented nucleus (left) of a myeloma cell and its
pseudo 3D transformation (middle). On the right side, the log-log-
plot for the determination of the fractal dimension (FD), which is
calculated from the slope of the ideal regression line (black) obtained
by curve fitting. X-axis shows the logarithms of the inverse values of the
size of the structuring element and y axis the logarithmic values of the
fractal areas. (compare with the main text). R2 represents the goodness-
of-fit of the real values (red), when compared with ideal regression line
(black) and can be interpreted as a measure of ‘‘fractal quality’’.
doi:10.1371/journal.pone.0020706.g001
Fractality of Chromatin in Multiple Myeloma
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e20706
For each nucleus, classical morphometric parameters such as
nuclear area and the circular form factor (the ratio between
perimeter of a circle with the same area as the nucleus and the
actual nuclear perimeter) were calculated. In addition, the fractal
dimension of each nucleus was determined.
The fractal dimension of an object is, in many studies, measured
after binarization of the image. Since we were dealing with 256
gray levels, binarization would be arbitrary and reduce the
information content [10,37,38]. Therefore we decided not to
binarize, but to apply the Minkowski-Bouligand method extended
to pseudo-3D images [10,39,40,41]. We created landscape-like
pseudo-3D images, where the x and y coordinates represented the
position of the pixel, and the z coordinate, its grey level (Fig. 1).
The fractal dimension (FD) of the surface of the pseudo- 3-D
images was calculated using a software developed in house by our
group. In brief, we calculated the fractal area which is estimated by
the volume/2e with e being the radius, varying between 1 and 30
pixels, of the non-planar structuring element in form of a ball.
Then, we calculated the linear regression in a log-log plot of the
fractal area versus e, with each plot containing 30 points
(Fig. 1).We rotated the point distribution so that the slope was at
45 degrees. Then, the coefficient of the regression between the real
and the estimated values was calculated [40,41]. This R2 value
characterizes the goodness-of-fit of the regression line and is
therefore an estimate of the ‘‘quality of fractality’’. An ideal fractal
has a R2 = 1.0. The real fractals have R2 values ,1.0 [41].
In a preliminary study we have found that the cumulative
histograms for FD distribution in individual cases stabilized after
examination of 25–35 cells (Fig. 2). Therefore, we decided to
acquire at least 40 cells per smear.
Finally, the prognostic relevance of all these parameters was
analyzed in univariate and multivariate Cox regressions (p = 0.05
for input and p = 0.1 for output, backward conditional step-wise
selection). The stability of the Cox model was tested by bootstrap
resampling. This is a useful procedure to test the internal stability
of a model proposed. It consists of creating new data sets of equal
size by random sampling of the original data with replacement. In
an individual new bootstrap sample, a patient may be represented
once, multiple times or not at all. A new Cox regression (with the
same conditions as in the original data set) was then calculated for
each of these new data sets in order to obtain the bootstrap
parameter estimates. This procedure is very useful in order to
point out the most important variables [42,43]. SPSS 8.0 and
WinStat software were used for calculations.
In order to facilitate the comparison with previous studies that
used plasma cell morphology, we randomly selected 107 nuclear
images from our whole data pool and classified them in four
categories (Fig. 3) A: Nuclei with a mature chromatin structure; B:
immature nuclei with a less organized chromatin; C: Nuclei with a
loose chromatin and a large nucleolus; and D: Nuclei with
irregular and disorganized chromatin with many dark and light
spots. Then we compared the FDs and R2 values between the four
groups by analysis of variance followed by the least square
difference post-hoc test. Differences were considered significant
when p,0.05.
Results
Sixty seven patients entered the study: 39 men and 28 women.
The clinical data are shown on table 1. Median age was 56 years.
According to ISS there was a predominance of advanced cases.
Additional features of a very bad prognosis were found in 46% of
the patients. Among them, a b2-microglobulin value .10 mg/L
was found in 37%, platelets were ,1306109/L in 21%, creatinine
was .4 mg/dL in 15% and albumin was ,2.5 g/dL in 19% of
the patients. The mean follow-up was 25.4 months (1–227). At the
end of the observation period 36 patients had died from multiple
myeloma, 24 of them before having completed the VAD regimen.
ISS (Fig. 4) was a significant adverse prognostic factor in the
univariate Cox regression (stage I: B = 22.30; stage II B = 21.50;
stage III: B = 0.0; p = 0.002). Patients belonging to the very poor
prognostic group had a significant shorter survival (median 12.1
Figure 2. Mean fractal dimension as a function of the number
of nuclei examined in an individual case. The mean value
stabilized after examination of 30–40 cells.
doi:10.1371/journal.pone.0020706.g002
Figure 3. Segmented images of myeloma cell nuclei, classified
by their grade of maturity and chromatin structure. A: Nucleus
with a more mature chromatin structure; its FD was 2.074935 and
R2 = 0.999330. B: a more immature nucleus with a less organized
chromatin structure presenting FD = 2.223 and R2 = 0.99896. C: Nucleus
with a blastic feature: FD = 2.1759 and R2 = 0.9961. D: Nucleus with
irregular and disorganized chromatin: FD = 2.2629 and R2 = 0.99931.
doi:10.1371/journal.pone.0020706.g003
Table 1. Clinical variables of the patients.
Variables Median and range
Age (years) 56 (30–85)
ISS Stage I 10 (14%)
ISS stage II 26 (39%)
ISS stage III 31 (47%)
Hemoglobin g/dL 9.2 (3.5–14.5)
Leukocytes 6109/l 6.1 (1.8–28.2)
Platelets 6109/l 211 (16–580)
b2-microglobulin (mg/dL) 10.3 (1.7–290.0)
Creatinine (mg/dL) 1.3 (0.2–6.8)
Albumin g/dL 3.3 (1.1–5.8)
Calcium (mg/dL) 9.3 (6.7–16.3)
doi:10.1371/journal.pone.0020706.t001
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months) than all other patients (median 101.6 months)
(B = 0.7562; p = 0.0302) (Fig. 5).
Age, serum calcium concentration, hemoglobin value, PB
platelet count, BM percentage of myeloma cells, nuclear area
and form factor had no prognostic relevance.
The morphometric features studied are shown in table 2. The
fractal dimension (FD) was an adverse prognostic feature
(B = 12.33; p = 0.0287). Only in order to illustrate the importance
of FD as a prognostic variable, we dichotomized the continuous
variable FD according to a cluster analysis (Ward algorithm),
which suggested as cut-point at FD = 2.13 and then created a
Kaplan-Meier-plot (Fig. 6). The goodness-of -fit (R2) was a
favorable prognostic factor in the univariate Cox regression when
stratified for ISS (B = 2592.6; p = 0.10) (table 3).
Cytogenetic analysis revealed hyperdiploidy in 12 cases,
alterations of chromosome 13 in 2 patients, 2 cases with
translocations involving chromosome 14 (in one case together
with 217) and 1 patient with hypodiploidy. The number of
cytogenetic abnormalities was an adverse prognostic factor in the
univariate Cox regression (B = 0.8833; p = 0.0387).
The nuclear area, form factor, FD and goodness-of-fit did not
correlate with ISS stage or laboratory parameters, such as serum
calcium concentration, b2-microglobulin, albumin, creatinine,
hemoglobin value, PB platelet count and BM percentage of
myeloma cells (Spearman rank order test). We could not detect
any statistical relation between presence or number of chromo-
somal abnormalities and FD (Spearman rank order correlation).
Looking at the morphology of the neoplastic plasma cell nuclei
(Fig. 3), mature plasma cells showed significantly the lowest fractal
dimension (FD = 2.08) whereas the FDs of all other cell types were
significantly higher (FD immature = 2.15; FD blasts = 2.18 and
FD irregular nuclei = 2.16). There was, however, no statistically
significant difference between these three cell types. Goodness-of-
fit was significantly lowest for cells with irregular nuclei
(R2 = 0.9978), followed by blasts (R2 = 0.9987). Mature (0.9993)
and immature (0.9993) plasma cells revelaed significantly the
highest values, yet without any difference between them.
Finally, all variables with p#0.10 in the univariate analyses
(ISS, very poor risk group, FD, R2 FD and cytogenetic alterations)
were simultaneously analyzed in a multivariate proportional
hazard model. The final Cox regression included ISS (stage I:
B = 22.13; stage II: B = 21.75; stage III: B = 0.0; p = 0.0004), FD
(B = 14.39; p = 0.015), R2 FD (B = 2935.12; p = 0.0317) and the
number of genetic alterations (B = 0.8862; p = 0.069), whereas the
variable ‘‘very poor prognosis group’’ did not enter the model.
The stability of this model was confirmed in a bootstrap
resampling procedure. Among 100 new models, ‘‘ISS’’ entered in
100%, ‘‘fractal dimension’’ in 77%, ‘‘R2 FD’’ in 68%, ‘‘number of
cytogenetic abnormalities’’ in 60%, but ‘‘very poor prognosis
group’’ entered in none of the models.
Figure 4. Overall survival of the myeloma patients categorized
by ISS stage. Kaplan-Meier plot. Log rank-test: p = 0.0005.
doi:10.1371/journal.pone.0020706.g004
Figure 5. Overall survival categorized by the presence or
absence of additional risk factors [2]. Kaplan-Meier plot. Log rank-
test: p = 0.02.
doi:10.1371/journal.pone.0020706.g005
Figure 6. Survival of the patients grouped by FD. Kaplan-Meier
plot. Log rank-test: p = 0.05.
doi:10.1371/journal.pone.0020706.g006
Table 2. Morphometric variables of the nuclei of the
myeloma cells.
Variables Median and range
Nuclear area (mm2) 64.0 (42.1–99.7)
Form factor 0.5195 (0.4362–0.5651)
FD Minkowski 2.113 (2.071–2.278)
R2 0.99875 (0.99642–0.99997)
doi:10.1371/journal.pone.0020706.t002
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Discussion
The median age of our patients at diagnosis was 56 years, which
is considerably lower than that reported in studies on MM from
North America, Europe or Asia [2,44]. A younger age of the
patients at diagnosis, when compared with other countries, has
also been reported for other hematological neoplasias in Brazil,
such as myelodysplastic syndromes and myeloid leukemias [45–
51]. Besides that, a recent epidemiological survey of patients with
multiple myeloma in our country showed a similar mean age and
also a high frequency of advanced ISS [45]. No final conclusive
explanation has been found for this phenomenon. But one might
speculate that this could be due to a high exposure to carcinogenic
agents in Brazil. It has been shown that herbicides and pesticides
are risk factors for the genesis of multiple myeloma [52]. But not
only farm workers with direct contact to these toxins are at risk.
The general population may be frequently exposed to residual
toxins in food [53,54].
Our patients showed a high frequency of advanced disease
according to the ISS and additional poor risk factors. This resulted
in a median survival of 24.9 months for all patients, much shorter
than that reported by other studies [2,45]. There are several
possible explanations for this phenomenon. Delayed diagnosis in
patients who depend on a public health system, as in our case, is
not rare. In addition, unawareness of symptoms or indolence
might be common in patients from lower socio-economic classes.
And finally, a more aggressive character of MM in our country
cannot be totally excluded. The patients with additional poor
prognostic factors had a median survival of about 12.1 months,
which is close to that reported by Greipp at al [2]. However, only
5% of the total population reported in that study had these criteria
for additional high risk.
The International Staging System (ISS), based only on two
laboratory variables, the b2-microglobulin and albumin serum
concentrations, has replaced the Durie-Salmon staging system in
2005 and is currently considered standard for staging of myeloma
[2,5,51]. It was further validated in patients in North America,
Europe, and Asia; in patients below and above 65 years of age; in
patients with standard therapy or autologous bone marrow
transplantation; and in comparison with the Durie/Salmon
staging system. The prognostic importance of this staging system
was confirmed in our study.
Regarding the great variability of myeloma pathophysiology,
there are additional prognostic factors, such as age, hemoglobin
concentration, serum creatinine and calcium levels. But, this could
not be confirmed in our investigation. Since the number of
patients was relatively small, the test power was limited and we
may have missed to demonstrate them as significant risk factors.
Special attention was drawn to prognostic factors, which could
improve a risk-stratification model able to define high-risk patients
who can benefit from novel therapeutic strategies.
Plasma cell cytogenetic abnormalities and labeling index have
also shown to be of prognostic value, but, these techniques require
fresh unfixed material, are sophisticated and expensive, and can be
performed only in few laboratories. Therefore it would be
interesting to look for additional prognostic factors, which are
not cost-expensive, can be examined retrospectively and be
assessed independently of a specialized laboratory.
Cell morphology, evaluated subjectively by a trained observer,
has also been considered a prognostic variable in multiple
myelomas [6] but the drawback of this method is the considerable
inter-observer variability. Goasguen et al. developed a protocol for
morphologic analysis of myeloma cells based on more objective
morphologic criteria in routinely stained slides [6]. These criteria
included the presence of a nucleolus, blast-like chromatin and a
nuclear-cytoplasmatic ratio .0.6, thus creating 8 possible
subtypes. This procedure was able to identify an intermediate
prognostic subgroup of patients, but the method was still
dependent on a trained human observer [6]. Leleu et al [1]
described in detail the nuclear shape changes in myeloma cells and
created the variable ‘‘percentage of plasma cells with irregular
nuclear shape’’. This variable was a prognostic factor in the
univariate analysis and significantly associated with other prog-
nostic parameters such as Ki67 labeling index, hemoglobin values
and hypodiploidy, but not with beta-2-microglobulin. In both
studies, however, morphologic variables were not independent risk
factors in multivariate regressions.
Computerized analysis of microscopic images overcomes the
necessity of morphologic expertise and expert opinion and has
shown to be an objective and reproducible method for diagnostic
and prognostic purposes [33,55–57]. Image analysis is able to
detect subtle morphologic changes which cannot be recognized
even by a trained observer [23,56–58]. Among these techniques,
the examination of the fractal characteristics of nuclear chromatin
has shown to be of increasing importance [59–64].
The use of the fractal concept for image analysis has several
advantages. The fractal dimension has shown to be robust against
the segmentation process [63]. In routine cytological preparations
fractal derived variables are much less dependent on staining
variations than variables derived from the grey-level co-
occurrence matrix [61]. Form factors, which are classically used
for the quantitative description of irregular outlines, depend
highly on the magnification scale, whereas fractals are scale
independent [62].
The fractal dimension represents a statistical description but,
moreover, is also intimately related to the theoretical concepts of
complexity and morphogenesis. Therefore it provides a deeper
insight into the understanding of the biology of normal tissues and
neoplasias [16,28]. The fractal concept, developed by Mandelbrot
[64] in the sixties and seventies of the last century got popularity
due to the famous images created by computer programs based on
fractal geometry. It is however a ubiquitous theoretical framework
for many processes or objects in our known universe. Fractality
implies scale-independent self-similarity or self-affinity. The fractal
concept may be applied to every kind of science. Fractal
characteristics can be found when measurement values of a
certain variable are scale independent so that in a log-log plot the
measurement points can be well approximated by a regression
line. Therefore the fractal property is always related to a
measurement variable. An ‘‘object’’ or a ‘‘process’’ can reveal
simultaneously fractal characteristics of many different variables or
features.
Table 3. Factors influencing the survival of the patients,
analyzed by the univariate Cox regression.
B p
ISS stage l 22.30 0.001
ISS stage II 21.50 0.025
ISS stage III 0.00 0.001
Very poor prognostic group 0.756 0.03
Cytogenetics 0.883 0.038
FD Minkowski 12.33 0.028
R 2 (stratified by ISS) 2592.6 0.10
doi:10.1371/journal.pone.0020706.t003
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Introducing the fractal concept in biology and medicine has
improved our understanding of many physiological processes, such
as allometric scaling growth, allosteric enzyme kinetics, intracel-
lular bio-energetic dynamics, metabolic rate in mammals,
population genetics, modeling of drug clearance, neo-angiogenesis,
tumor growth, organization of nucleotides in DNA and RNA, and
cardiovascular physiology [16,18,21,65–68]. Fractals are very
useful to characterize properly the complexity of macroscopic and
microscopic anatomy, namely to describe the design principles
underlying living organisms.
The chromatin structure can also be analyzed by fractal
geometry [10,14,16,17,22,23,63–68].
Fractal structures can be created by iterations [69]. This
happens for instance during condensation of a polymer such as
DNA when it is repeatedly subjected to the self-similar process of
crumpling. The result is a folded polymer with fractal properties.
In this way, a long polymer can be packed in a small volume
without entanglements. This facilitates unravelling when neces-
sary, as for DNA transcription, and is therefore advantageous for
cell physiology [68]. Recent studies using different methods of
analysis showed that DNA, nuclear chromatin and the surround-
ing nucleoplasmic space have a fractal organization [26–28,68],
Our study revealed that the staining pattern of nuclear
chromatin of myeloma cells, (May-Grünwald –Giemsa method)
has also fractal characteristics. An important challenge is to
explain, why patients with a worse prognosis, revealed an
increased FD of the chromatin staining pattern in May-Grünwald
–Giemsa stained smears. Changes of the nuclear architecture,
observed in histological or cytological preparations, reflect
genomic and non-genomic alterations.
Multiple genetic aberrations have been described during the
pathogenesis of multiple myelomas [70]. Secondary translocations
and gene mutations have been implicated in disease progression, such
as complex abnormalities of MYC, activation of N-RAS, K-RAS,
and FGFR3 mutations, mutations or deletions of TP53, RB1, and
PTEN and inactivation of cyclin-dependent kinase inhibitors [71,72].
Furthermore, epigenetic changes causing altered gene and
protein expression play a major role in the pathogenesis of
multiple myelomas. Hypermethylation of the genes p15, p16,
DAP-kinase, BAD, BAK, BAX, BIK, SOCS-1, and E-Cadherin,
has been reported [71,72].
Hypermethylation of CpG islands within gene promoter regions
accompanied by deacetylation of histone proteins provokes
transcriptional silencing. In parallel, global hypomethylation of
repetitive elements occurs in association with tumor progression
and increase of chromosomal instability [71,72]. Therefore, in
advanced cases, which are genetically unstable and therefore more
aggressive, we expect a more complex chromatin rearrangement
with global hypomethylaton and an increased number of
hypermethylated CPG islands.
The routinely MGG stained cytologic smears permit to estimate
the topographic localization of methylated regions in the nucleus.
Co-localization analysis has shown that the deeply Giemsa-stained
compacted heterochromatin domains have the same geographic
distribution as the methyl-rich regions within each nucleus [73].
Therefore, aggressive myelomas should have a more complex
chromatin structure with an increased number of darker and
lighter areas, leading to a higher fractal dimension of the nuclear
chromatin, as found in our study.
Indeed, the FD of MGG-stained nuclear chromatin showed to
be an independent adverse prognostic factor for the overall
survival of our patients. In a similar way, previous studies have
demonstrated an association between a higher FD value of the
nuclear chromatin and a worse outcome of patients with other
neoplasias, such as malignant melanomas, squamous cell carcino-
mas of the oral cavity and larynx [14,28-31].
This implies that the complexity of chromatin distribution
contains important prognostic information which is independent
of clinical variables, ISS stage, or relevant cytogenetic aberrations.
In the present study, the frequency of cytogenetic abnormalities
was low when compared to other reports [2,3]. Technical
problems, however, could have precluded the finding of some
abnormalities.
The goodness-of-fit of the fractal dimension was also of
independent prognostic relevance, but as a favorable factor. Thus
a chromatin architecture closer to the "ideal fractal" was
associated with a prolonged survival of the patient, as it has been
shown previously for blasts of B precursor acute lymphatic
leukemia [10].
Explanations for this finding are speculative at the moment. But
it might be possible that the large number of genetic and
epigenetic modifications in aggressive tumors could disturb the
process of auto-organization of the nucleus to such an extent that
the scale-free auto-similarity of chromatin structures is not as
perfect as in less aggressive cases.
Our study revealed that both the fractal dimension and its
goodness-of-fit permit to quantify DNA remodeling and methyl-
ation status in MGG-stained bone marrow smears of myeloma
patients and therefore may be new and biologically relevant
prognostic factors for this disease. A more detailed scientific
validation of the texture analyses is necessary, of course. Data from
genome-wide methylation or chromatin analyses should be
compared with fractal data derived from digitalized images of
routinely stained tumor smears or sections, in order to define
better the equivalence between changes of the image texture and
genome-wide biochemical chromatin changes.
Since there is a vast heterogeneity of molecular profiles among
myeloma patients, detailed individual genomic evaluations for
targeted therapies seem not to be helpful at the moment, as has
been emphasized recently [74].
In this situation, a global evaluation of the nucleus, as presented
in this investigation, could be interesting. This technique is simple,
reproducible and unexpensive and may be applied to routine slides
from the files, thus permitting retrospective studies without any
additional costs. Therefore, we think it could be useful in daily
routine practice in future. But since our study was based on a
relatively small number of patients, it should, of course, be
followed by confirmatory investigations based on more and new
patients in different centers [75].
Author Contributions
Analyzed the data: DPF MAF RLA CSPL IL-M KM CAS. Conceived the
study: KM. Coordinated the study: KM. Designed the study: KM IL-M.
Acquired and analyzed the nuclei: DPF. Collected the clinical and
laboratory data: DPF. Performed statistical analysis: DPF. Performed all
the cytogenetic analysis: MMO. Elaborated the software: RLA. Partici-
pated in the elaboration of the treatment protocol: CSPL. Supervised the
cytogenetic analysis: CSPL. Made a critical revision of the manuscript:
CSPL. Conducted the clinical protocol: CAS.
References
1. Leleu X, Genevieve F, Guieze R, Duhamel A, Andrieux J, et al. (2005) Irregular
nuclear shape of bone marrow plasma cells defines a multiple myeloma
subgroup related to hypodiploidy and to short survival. Leukemia 29: 665–
671.
Fractality of Chromatin in Multiple Myeloma
PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e20706
2. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, et al. (2005)
International staging system for multiple myeloma. J Clin Oncol 23: 3412–20.
3. Tinguely M, Jenni B, Reineke T, Korol D, Kofler A, et al. (2007) Chromosomal
translocations t(4;14), t(11;14) and proliferation rate stratify patients with mature
plasma cell myelomas into groups with different survival probabilities - A
molecular epidemiologic study on tissue microarrays. Am J Surg Pathol 31:
690–6.
4. Ortega MM, Cunha AF, Albuquerque DM, Costa GL, De Souza CA, et al.
(2008) Identification of new overexpressed genes related to cell proliferation,
stimulation and apoptosis inhibition of plasma cells of multiple myeloma by Sage
method. Ann Oncol 19: 230.
5. Rajkumar SV, Buadi F (2007) Multiple myeloma: new staging systems for
diagnosis, prognosis and response evaluation. Best Pract Res Clin Haematol; 20:
665–80.
6. Goasguen JE, Zandecki M, Mathiot C, Scheiff JM, Bizet M, et al. (1999) Mature
plasma cells as indicator of better prognosis in multiple myeloma. New
methodology for the assessment of plasma cell morphology. Leukemia Res 23:
1133–1140.
7. Genty V, El-Khoury V, Liautaud-Roger F, Dine G, Dufer J (2005) Nuclear
chromatin patterns in 3 glucocorticoid-resistant RPMI 8226 human myeloma
cell sub-lines: correlations with cell growth and immunological phenotype.
Cancer Biol Ther 4: 832–9.
8. Metze K, Adam RL, Kayser G, Kayser K (2010) Pathophysiology of cancer and
the entropy concept, Model-Based Reasoning in Science and Technology.
Studies in Computational Intelligence 314, 199-206.
9. Metze K, Oliveira GB, Pereira FG, Adam RL, Lorand-Metze I (2005)
Spontaneous apoptosis in chronic lymphocytic leukemia is not an independent
prognostic factor for stability of disease when compared with combined AgNOR
and TTM scores. Cell Oncology 27: 199–201.
10. Adam RL, Silva RC, Pereira FG, Leite NJ, Lorand-Metze I, et al. (2006) The
fractal dimension of nuclear chromatin as a prognostic factor in acute precursor
B lymphoblastic leukemia. Cell Oncol 28: 55–9.
11. Montironi R, Scarpelli M, Lopez-Beltran A, Mazzucchelli R, Alberts D, et al.
(2007) Chromatin phenotype karyometry can predict recurrence in papillary
urothelial neoplasms of low malignant potential. Cell Oncol 29: 47–58.
12. Metze K, Bedin V, Adam RL, Cintra ML, de Souza EM, et al. (2005)
Parameters derived from the fast Fourier transform are predicitive for the
recurrence of basal cell carcinoma. Cell. Oncol 27: 137.
13. Nielsen B, Albregtsen F, Kildal W, Danielsen HE (2001) Prognostic classification
of early ovarian cancer based on very low dimensionality adaptive texture
feature vectors from cell nuclei from monolayers and histological sections. Anal
Cell Pathol 23: 75–88.
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